Imprimis Pharmaceuticals Acquires Proprietary Compounded Conscious Sedation Formulations
June 23, 2015 at 07:31 AM EDT
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on the development and commercialization of proprietary ...